Table 1.
Patient characteristics of the SLE cohort, SLE follow-up patients, health control, and disease control.
| SLE | SLE follow-up | HC | DC | ||
|---|---|---|---|---|---|
| Number of patients | 851 | 61 | 211 | 194 | |
| Sex [n (%)] | |||||
| Women | 776 (91.2) | 54 (88.5) | 192 (91.0) | 186 (95.9) | |
| Men | 75 (8.8) | 7 (11.5) | 19 (9.0) | 8 (4.1) | |
| Age (mean ± SD; years) | 40.1 ± 13.8 | 41.89 ± 13.53 a | 40.6 ± 13.6 | 41.4 ± 12.8 | |
| Disease duration of SLE [median (IQR); years] | 5.0 (1.0–10.0) | 4.0 (1.7–9.5) a | N/A | N/A | |
| SLEDAI-2K [median (IQR)] | 8.0 (4.0–12.0) | 6.0 (2.0–9.0) a | N/A | N/A | |
DC, disease control; HC, healthy control; IQR, interquartile range; N/A, not applicable; SD, standard deviation; SLE, systemic lupus erythematosus; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2000.
a
Data of the follow-up group at the time of enrollment.